Page last updated: 2024-11-04

temozolomide and Neoplasms, Pleural

temozolomide has been researched along with Neoplasms, Pleural in 3 studies

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to investigate the anti-tumour activity of temozolomide in patients with malignant pleural mesothelioma."9.10A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma. ( Baas, P; Debruyne, C; Galdermans, D; Giaccone, G; Lentz, MA; Manegold, C; Smit, EF; van Klaveren, RJ; van Meerbeeck, JP, 2002)
"Nonislet cell tumor hypoglycemia is rare."6.58Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome. ( Hilsenbeck, HL; Nyenwe, EA; Ogunsakin, AA; Portnoy, DC, 2018)
"The aim of this study was to investigate the anti-tumour activity of temozolomide in patients with malignant pleural mesothelioma."5.10A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma. ( Baas, P; Debruyne, C; Galdermans, D; Giaccone, G; Lentz, MA; Manegold, C; Smit, EF; van Klaveren, RJ; van Meerbeeck, JP, 2002)
"Nonislet cell tumor hypoglycemia is rare."2.58Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome. ( Hilsenbeck, HL; Nyenwe, EA; Ogunsakin, AA; Portnoy, DC, 2018)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Maeda, O1
Ohka, F1
Maesawa, S1
Matsuoka, A1
Shimokata, T1
Mitsuma, A1
Urakawa, H1
Nakamura, S1
Shimoyama, Y1
Nakaguro, M1
Wakabayashi, T1
Ando, Y1
Ogunsakin, AA1
Hilsenbeck, HL1
Portnoy, DC1
Nyenwe, EA1
van Meerbeeck, JP1
Baas, P1
Debruyne, C1
Smit, EF1
van Klaveren, RJ1
Galdermans, D1
Lentz, MA1
Manegold, C1
Giaccone, G1

Reviews

1 review available for temozolomide and Neoplasms, Pleural

ArticleYear
Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome.
    The American journal of the medical sciences, 2018, Volume: 356, Issue:2

    Topics: Bevacizumab; Female; Fibroma; Humans; Hypoglycemia; Middle Aged; Pleural Neoplasms; Temozolomide

2018

Trials

1 trial available for temozolomide and Neoplasms, Pleural

ArticleYear
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Disease-Free Survival; Female; Humans;

2002

Other Studies

1 other study available for temozolomide and Neoplasms, Pleural

ArticleYear
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review.
    Nagoya journal of medical science, 2020, Volume: 82, Issue:4

    Topics: Antineoplastic Agents, Immunological; Bevacizumab; Drug-Related Side Effects and Adverse Reactions;

2020